Article
<i>In silico</i> analysis of the Chikungunya virus and SARS-CoV-2 Macrodomain
2025-10-12
Abstract excerpt
The macrodomain of the Chikungunya virus NSP3 protein (ChikV Mac1) hydrolyzes mono-ADP ribose post-translational modifications on the human host proteins. Mutations in Mac1 reduce ChikV virulence. Thus, ChikV Mac1 is a viral drug target. While no potent ChikV Mac1 inhibitors are available, high-affinity inhibitors were developed for Mac1 in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Here, we rat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7b6e3849-53f4-53b4-ab55-ad4ad5a88832
- DOI
- 10.1101/2025.10.10.681726
